Table 2. Mortality effect of high inclusion suPAR according to HIV and smear status.
| Mortality rate per 100 person-years(deaths/person-years of follow-up) [N] | Mortality rate Ratio1 | Mortality rate Ratio2 | ||
| suPAR quartile 1–3(1.7–8.4 ng/ml) | suPAR quartile 4(8.4–54.0 ng/ml) | |||
| Smear Positive & Smear Negative | ||||
| HIV negative | 6.8 (6/88.0) [135] | 5.8 (1/17.1) [26] | 0.86 (0.10–7.12) | 0.00 (−) |
| HIV positive | 20.0 (8/40.1) [64] | 57.5 (9/15.7) [28] | 2.85 (1.10–7.40) | 4.46 (1.27–15.6) |
| HIV status missing | 17.3 (1/5.8) [9] | 74.9 (6/8.0) [16] | 4.29 (0.52–35.7) | 3.78 (0.22–64.1) |
| Overall | 11.2 (15/134.1) [208] | 39.2 (16/40.8) [70] | 3.47 (1.72–7.03) | 2.84 (1.17–6.89) |
| Smear Positive only | ||||
| HIV negative | 1.4 (1/69.2) [104] | 6.6 (1/15.1) [23] | 4.55 (0.28–72.8) | 0.00 (−) |
| HIV positive | 26.9 (7/26.1) [43] | 77.5 (8/10.3) [20] | 2.81 (1.02–7.77) | 5.44 (0.99–29.8) |
| HIV status missing | 32.0 (1/3.1) [5] | 100.0 (6/6.0) [13] | 3.08 (0.37–25.6) | 1.56 (0.08–30.4) |
| Overall | 9.2 (9/98.4) [152] | 47.7 (15/31.4) [56] | 5.09 (2.23–11.7) | 3.71 (1.25–11.1) |
1
Using time since treatment initiation as underlying time.
2
Using age as underlying time.